Eden Prairie, MN, United States of America

Brian L Miller

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 173(Granted Patents)


Location History:

  • Eden Praire, MN (US) (2006)
  • Eden Prairie, MN (US) (2009 - 2014)

Company Filing History:


Years Active: 2006-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Brian L. Miller: Innovator in Gamma-Hydroxybutyrate Compositions

Introduction

Brian L. Miller is a notable inventor based in Eden Prairie, MN (US). He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on gamma-hydroxybutyrate (GHB) formulations. With a total of 3 patents to his name, Miller's work has the potential to enhance drug delivery systems.

Latest Patents

Miller's latest patents include innovative compositions that incorporate GHB moieties bonded to physiologically compatible carrier molecules. These compositions are designed to improve the uptake of the drug, deliver effective therapeutic doses in a time-delayed manner, and target specific organs. This advancement in drug formulation could lead to more effective treatments for various medical conditions.

Career Highlights

Throughout his career, Brian L. Miller has been associated with Orphan Medical, Inc., where he has focused on developing groundbreaking pharmaceutical solutions. His expertise in drug formulation has positioned him as a key player in the industry, contributing to advancements that could benefit patients significantly.

Collaborations

Miller has collaborated with notable colleagues, including Mortimer Mamelak and William C. Houghton. These partnerships have fostered an environment of innovation and have led to the development of impactful pharmaceutical compositions.

Conclusion

Brian L. Miller's contributions to the field of gamma-hydroxybutyrate compositions highlight his role as an influential inventor. His work continues to pave the way for advancements in drug delivery systems, showcasing the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…